Emerging investigations suggest that Delta-Sleep-Inducing Peptide Compound represents an intriguing clinical candidate. Initial data show a contribution in regulating sleep and possibly treating several neurological and psychiatric conditions . Additional exploration are needed to fully understand its process of impact and validate a practical ben